Oxazolidinonantibiotika

Patent europeic · EP2915813 · Stritgà

Inscripziun en il register

Numer da publicaziun
EP2915813
Numer da la dumonda
EP15154086
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
Stritgà
Scrittira da patent
Concedì
Annunzià
11-04-2008
Publitgà
09-09-2015
Concedì
01-02-2017
Stritgà
30-04-2019
Motiv
Taxa annuala betg pajada
Classas IPC
C07D 471/04 (2006.01)
A61K 31/435 (2006.01)
A61P 31/00 (2006.01)
Prioritad
WO PCT/IB2007/051290 11.04.2007
WO PCT/IB2007/054587 12.11.2007
WO PCT/IB2007/054768 23.11.2007
Derivà da
EP08737800
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 20-11-2019

    Stritgà, taxa betg pajada

    Published in Swissreg on 20.11.2019

  2. 14-09-2017

    Transferì

    Owner
    Actelion Pharmaceuticals Ltd., Gewerbestrasse 16, 4123 Allschwil → Idorsia Pharmaceuticals Ltd, Hegenheimermattweg 91, 4123 Allschwil

    Published in Swissreg on 14.09.2017

  3. 01-02-2017

    Concedì

    Published in Swissreg on 01.02.2017

Partidas

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.